No Data
No Data
We Think Cabaletta Bio (NASDAQ:CABA) Can Afford To Drive Business Growth
Express News | HC Wainwright & Co. Reiterates Buy on Cabaletta Bio, Maintains $30 Price Target
Cabaletta Bio Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 136.41% HC Wainwright & Co. → $30 Reiterates Buy → Buy 04/05/2024 294.01% Cantor Fitzgerald → $
Express News | Cabaletta Bio Inc : Jefferies Cuts Target Price to $31 From $36
Cabaletta Bio's Promising Clinical Advancements and Stable Financial Outlook Merit a Buy Rating
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results.Bolt Biotherapeutics posted a GAAP loss of 28 cent
No Data
diamonds : 请问,ENDPQ重组后,持有的股票还能有效吗?